Abstract
To profile the characteristic and prognostic implications of venous thromboembolism (VTE) in Chinese ovarian clear cell carcinoma (CCC) patients. We identified all of the cases between 2000 and 2012 by searching our institutional Ovarian CCC Database. A comprehensive review of the medical documentation was performed to collect relevant data. Kaplan-Meier models and Cox regression were employed for survival analysis. Of the 227 patients, 33 (14.5%) experienced VTE events. There was no significant difference between VTE and non-VTE group patients regarding age, serum cancer antigen 125 or tumor size. The optimal cytoreduction rate was higher in patients without VTE (70.1%) than in those with VTE (51.5%). VTE events were more likely to occur at presentation (36.4%) and recurrence (33.3%), followed by an adjuvant chemotherapy period (18.2%). VTE was more common in patients with advanced-stage disease than those with early-stage disease (P=0.003), whereas pulmonary embolism (PE) was 10-fold as common in advanced-stage disease as in early-stage disease (8.6% vs. 0.8%, P = 0.012). Patients with advanced disease tended to have thrombi in the proximal veins. Two patients died of PE, as confirmed by autopsy. Patients with VTE had reduced...Continue Reading
References
Dec 16, 2000·The New England Journal of Medicine·H T SørensenJ A Baron
Jun 20, 2003·Circulation·Agnes Y Y Lee, Mark N Levine
Apr 21, 2005·Journal of the National Cancer Institute·Pierluigi Benedetti PaniciCostantino Mangioni
Jul 14, 2006·Critical Reviews in Oncology/hematology·M MandalàUNKNOWN working group AIOM
Oct 4, 2006·Gynecologic Oncology·Yusuke MatsuuraNeville F Hacker
Oct 25, 2006·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Dimitrios Scarvelis, Philip S Wells
Apr 6, 2007·Gynecologic Oncology·Anne O RodriguezRichard H White
Apr 24, 2007·Gynecologic Oncology·M Heather EinsteinEllen M Hartenbach
Sep 27, 2007·British Journal of Cancer·T SatohH Yoshikawa
May 22, 2009·Archives of Gynecology and Obstetrics·Myong Cheol LimSang-Yoon Park
Nov 20, 2009·Gynecologic Oncology·Linda R DuskaNeil Horowitz
Mar 3, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andreas du BoisUNKNOWN Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens
Mar 26, 2010·Cancer·Rasanamar SandhuHelen K Chew
May 15, 2010·Thrombosis Research·Alexander T CohenSatoshi Ota
Jun 19, 2010·Japanese Journal of Clinical Oncology·Koji MatsumotoHiroyuki Yoshikawa
May 15, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gary H LymanUNKNOWN American Society of Clinical Oncology Clinical Practice
Sep 18, 2013·Gynecologic Oncology·Elena S DiazChristine S Walsh
Feb 22, 2014·Gynecologic Oncology·Pi-Lin SungUNKNOWN Task Force on Systematic Review and Meta-analysis of Ovarian Cancer
Aug 19, 2014·Nature Genetics·Chen WuStephen J Chanock
Oct 25, 2014·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Aikou OkamotoAmit Oza
Aug 12, 2015·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
Citations
Mar 6, 2016·Medicine·Shuang YeKeng Shen
Dec 20, 2015·Medicine·Shuang YeKeng Shen
Jul 20, 2019·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Hee Yeon LeeHo Jung An
May 10, 2017·Obstetrics and Gynecology·Patricia S GrecoShitanshu Uppal
Nov 23, 2020·Gynecologic Oncology·Yu XuAi Zheng
Mar 27, 2021·BMC Cancer·Chenchen ZhuYing Zhou
Apr 5, 2017·Journal of Gastrointestinal Cancer·Yuchen WangA J Tafur
Aug 19, 2021·Acta Clinica Belgica·Aglaja De PauwHannelore Denys